{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:01:56Z","timestamp":1767837716007,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/s11936-003-0001-4","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T09:13:13Z","timestamp":1180861993000},"page":"171-180","source":"Crossref","is-referenced-by-count":28,"title":["Thrombolytic therapy in acute ischemic stroke"],"prefix":"10.1007","volume":"5","author":[{"given":"Anthony J.","family":"Furlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene L.","family":"Katzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis R.","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.CIR.94.5.1167","volume":"94","author":"HP Adams","year":"1996","unstructured":"Adams HP, Brott TC, Furlan AJ, et al.: Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996, 94:1167\u20131174.","journal-title":"Circulation"},{"key":"1_CR2","doi-asserted-by":"crossref","unstructured":"Practice advisory: thrombolytic therapy for acute ischemic stroke\u2014summary statement. Quality Standards Subcommittee of the American Academy of Neurology [no authors listed]. Neurology 1996, 47:835\u2013839.","DOI":"10.1212\/WNL.47.3.835"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.STR.0000051504.10095.9C","volume":"34","author":"PD Schellinger","year":"2003","unstructured":"Schellinger PD, Fiebach JB, Hacke W, Rother J: Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003, 34:575\u2013583. The most upto-date description of modern brain and vascular imaging in acute stroke. Also shows how the results can be used to make decisions on thrombolysis.","journal-title":"Stroke"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ana.10136","volume":"51","author":"M Wintermark","year":"2002","unstructured":"Wintermark M, Reichhart M, Thiran J-P, et al.: Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002, 51:417\u2013432.","journal-title":"Ann Neurol"},{"key":"1_CR5","doi-asserted-by":"crossref","unstructured":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke Study Group [no authors listed]. N Engl J Med 1995, 333:1581\u20131587.","DOI":"10.1056\/NEJM199512143332401"},{"key":"1_CR6","first-page":"409","volume-title":"Cerebrovascular Diseases. Nineteenth Princeton Stroke Conference","author":"M Pessin","year":"1995","unstructured":"Pessin M, del Zoppo GJ, Furlan AJ: Thrombolytic treatment in acute stroke: review and update of selective topics. In Cerebrovascular Diseases. Nineteenth Princeton Stroke Conference. Edited by Moskowitz MA, Caplan LR. Boston: Butterworth-Heinemann; 1995:409\u2013418."},{"key":"1_CR7","first-page":"115","volume-title":"Caplan\u2019s Stroke, A Clinical Approach","author":"LR Caplan","year":"2000","unstructured":"Caplan LR: Treatment. In Caplan\u2019s Stroke, A Clinical Approach, 3rd edn. Boston: Butterworth-Heinemann; 2000:115\u2013161. Reviews stroke treatment and tabulates the results of thrombolysis in detail.","edition":"3rd edn"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(97)03022-5","volume":"350","author":"JM Wardlaw","year":"1997","unstructured":"Wardlaw JM, Warlow CP, Counsell C: Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997, 350:607\u2013614.","journal-title":"Lancet"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke W, Kaste M, Fieschi C, et al.: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017\u20131025.","journal-title":"JAMA"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998, 352:1245\u20131251.","journal-title":"Lancet"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","volume":"282","author":"WM Clark","year":"1999","unstructured":"Clark WM, Wissman S, Albers GW, et al.: Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA 1999, 282:2019\u20132026.","journal-title":"JAMA"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","volume":"276","author":"GA Donnan","year":"1996","unstructured":"Donnan GA, Davis SM, Chambers BR, et al.: Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 1996, 276:961\u2013966.","journal-title":"JAMA"},{"key":"1_CR13","doi-asserted-by":"crossref","unstructured":"Thrombolytic therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial\u2014Europe Study Group [no authors listed]. N Engl J Med 1996, 335:145\u2013150.","DOI":"10.1056\/NEJM199607183350301"},{"key":"1_CR14","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. The Multicenter Acute Stroke Trial\u2014Italy (MAST-I) Group [no authors listed]. Lancet 1995, 346:1509\u20131514.","DOI":"10.1016\/S0140-6736(95)92049-8"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","volume":"55","author":"JR Marler","year":"2000","unstructured":"Marler JR, Tilley BC, Lu M, et al.: Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000, 55:1649\u20131655.","journal-title":"Neurology"},{"key":"1_CR16","doi-asserted-by":"crossref","unstructured":"Generalized efficacy of t-PA for acute stroke. Sub-group analysis of the NINDS t-PA Stroke Trial [no authors listed]. Stroke 1997, 28:2119\u20132125.","DOI":"10.1161\/01.STR.28.11.2119"},{"key":"1_CR17","doi-asserted-by":"crossref","unstructured":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group [no authors listed]. Stroke 1997, 28:2109\u20132118.","DOI":"10.1161\/01.STR.28.11.2109"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.STR.29.1.18","volume":"29","author":"D Chiu","year":"1998","unstructured":"Chiu D, Krieger D, Villar-Cordova C, et al.: Intravenous tissue plasminogen activator for acute ischemic stroke, feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998, 29:18\u201322.","journal-title":"Stroke"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/01.STR.29.8.1544","volume":"29","author":"M Grond","year":"1998","unstructured":"Grond M, Stenzel C, Schmulling S, et al.: Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998, 29:1544\u20131549.","journal-title":"Stroke"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/WNL.54.3.679","volume":"54","author":"AM Buchan","year":"2000","unstructured":"Buchan AM, Barber PA, Newcommon N, et al.: Effectiveness of t-PA in acute ischemic stroke. Outcome relates to appropriateness. Neurology 2000, 54:679\u2013684.","journal-title":"Neurology"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","volume":"283","author":"GW Albers","year":"2000","unstructured":"Albers GW, Bates VE, Clark WM, et al.: Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000, 283:1145\u20131150.","journal-title":"JAMA"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.283.9.1151","volume":"283","author":"IL Katzan","year":"2000","unstructured":"Katzan IL, Furlan AJ, Lloyd LE, et al.: Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland Area Experience. JAMA 2000, 283:1151\u20131158.","journal-title":"JAMA"},{"key":"1_CR23","first-page":"3","volume":"14","author":"SM Wolpert","year":"1993","unstructured":"Wolpert SM, Bruckmann H, Greenlee R, et al.: Neuroradiology evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993, 14:3\u201313.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000331978303400901","volume":"34","author":"GG Nenci","year":"1983","unstructured":"Nenci GG, Gresele P, Taramelli M, et al.: Thrombolytic therapy of for thromboembolism of vertebrobasilar artery. Angiology 1983, 34:561\u2013571.","journal-title":"Angiology"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/01.STR.19.3.307","volume":"19","author":"GJ Zoppo del","year":"1988","unstructured":"del Zoppo GJ, Ferbert A, Otis S, et al.: Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 1988, 19:307\u2013313.","journal-title":"Stroke"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.STR.19.10.1216","volume":"19","author":"W Hacke","year":"1988","unstructured":"Hacke W, Zeumer H, Ferbert A, et al.: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216\u20131222.","journal-title":"Stroke"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00593977","volume":"35","author":"H Zeumer","year":"1993","unstructured":"Zeumer H, Freitag HJ, Zanella F, et al.: Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology 1993, 35:159\u2013162.","journal-title":"Neuroradiology"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3171\/jns.1996.84.3.0387","volume":"84","author":"GM Nesbit","year":"1996","unstructured":"Nesbit GM, Clark WM, O\u2019Neil OR, Barnwell SL: Intracranial intra-arterial thrombolysis facilitated by micro-catheter navigation through an occluded cervical internal carotid artery. J Neurosurg 1996, 84:387\u2013392.","journal-title":"J Neurosurg"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","volume":"29","author":"GJ Zoppo del","year":"1998","unstructured":"del Zoppo GJ, Higashida RT, Furlan AJ, et al.: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998, 29:4\u201311.","journal-title":"Stroke"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"282","author":"A Furlan","year":"1999","unstructured":"Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999, 282:2003\u20132011.","journal-title":"JAMA"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.52.5.1081","volume":"52","author":"IL Katzan","year":"1999","unstructured":"Katzan IL, Masaryk TJ, Furlan AJ, et al.: Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 1999, 52:1081\u20131084.","journal-title":"Neurology"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.STR.30.12.2598","volume":"30","author":"CA Lewandowski","year":"1999","unstructured":"Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy for acute ischemic stroke. Emergency Management of Stroke (EMS) bridging trial. Stroke 1999, 30:2598\u20132605.","journal-title":"Stroke"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.STR.19.10.1216","volume":"19","author":"W Hacke","year":"1988","unstructured":"Hacke W, Zeumer H, Ferbert A, et al.: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988, 19:1216\u20131222.","journal-title":"Stroke"},{"key":"1_CR34","first-page":"38","volume":"369","author":"H Br\u00fcckmann","year":"1987","unstructured":"Br\u00fcckmann H, Ferbert A, del Zoppo G, et al.: Acute basilar thrombosis: angiologic-clinical comparison and therapeutic implications. Acta Radiol 1987, 369(suppl):38\u201342.","journal-title":"Acta Radiol"},{"key":"1_CR35","unstructured":"Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: the era of reperfusion: section 2: acute stroke. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation [no authors listed]. Circulation 2000, 102(8 suppl):I204\u2013I216."},{"key":"1_CR36","first-page":"1257","volume":"18","author":"RC Wallace","year":"1997","unstructured":"Wallace RC, Furlan AJ, Moliterno DJ, et al.: Basilar artery rethrombosis: successful treatment with plate-let glycoprotein IIb\/IIIa receptor inhibitor. Am J Neuroradiol 1997, 18:1257\u20131260.","journal-title":"Am J Neuroradiol"},{"key":"1_CR37","doi-asserted-by":"crossref","unstructured":"Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in Ischemic Stroke Investigators [no authors listed]. Stroke 2000, 31: 601\u2013609.","DOI":"10.1161\/01.STR.31.3.601"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.STR.23.5.646","volume":"23","author":"R Kummer von","year":"1992","unstructured":"von Kummer R, Hacke W: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992, 23:646\u2013652.","journal-title":"Stroke"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.42.5.976","volume":"42","author":"E Mori","year":"1992","unstructured":"Mori E, Yoneda Y, Tabuchi M, et al.: Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992, 42:976\u2013982.","journal-title":"Neurology"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/01.STR.25.2.291","volume":"25","author":"DE Levy","year":"1994","unstructured":"Levy DE, Brott TG, Haley EC, et al.: Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994, 25:291\u2013297.","journal-title":"Stroke"},{"key":"1_CR41","first-page":"1115","volume":"12","author":"L Bozzao","year":"1991","unstructured":"Bozzao L, Angeloni U, Bastianello S, et al.: Early angio-graphic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol 1991, 12:1115\u20131121.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1212\/WNL.45.4.649","volume":"45","author":"MA Sloan","year":"1995","unstructured":"Sloan MA, Price TR, Petito CK, et al.: Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology 1995, 45:649\u2013658.","journal-title":"Neurology"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-003-0001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-003-0001-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-003-0001-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:52:28Z","timestamp":1559422348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-003-0001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11936-003-0001-4","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}